3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Classical hematology
1
Conditions
Carcinoma, Non-Small-Cell Lung
6
Lung Neoplasms
3
Venous Thromboembolism
1
Thoracic Neoplasms
1
Solid Tumor
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Noonan Syndrome
1
Neoplasms by Site
1
Neoplasms
1
Lung Diseases
1
Hereditary Sensory and Autonomic Neuropathies
1
Healthy Participants
1
Colorectal Neoplasms
1
Carcinoma
1
Bronchial Neoplasms
1
Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation
1
Interventions
apixaban
11
Dalteparin
10
Rivaroxaban
7
Enoxaparin
5
Fondaparinux
4
Tinzaparin
3
Heparin, Low-Molecular-Weight
3
Aspirin
3
edoxaban
2
Warfarin
2
Observation
2
Dabigatran
2
sotorasib
1
calcium heparin
1
betrixaban
1
bemiparin
1
argatroban
1
Tacrolimus
1
Tablets
1
Simvastatin
1
Rosuvastatin Calcium
1
Nadroparin
1
Heparin
1
Gemcitabine
1
Drug Therapy
1
Data Collection
1
Cyclosporine
1
AVE 5026
1
ALT-836
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Venous Thromboembolism
×
sotorasib
×
Clear all
NCT06314763
2024-04-30
ROSIE
Radboud University Medical Center
Phase 4
Completed
21 enrolled